INSTITUTE OF BIOMEDICAL SCIENCE

1. INSTITUTE OF BIOMEDICAL SCIENCE 1994-01-01 → present
2. INSTITUTE OF MEDICAL LABORATORY SCIENCES 1942-11-17 → 1994-01-01

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

HaysMac LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

1. INSTITUTE OF BIOMEDICAL SCIENCE · parent
   1. Institute of Biomedical Science (Professional Services) Ltd 100% · England and Wales · trading... running events (mainly Congress, a biennial event), providing secretarial support to other organisations and hire of meeting room facilities.

Significant events

• “In 2025, the IBMS delivered strong outcomes for members and the profession, while increasing its influence across health policy, education and public engagement.”
• “Awarded Life Memberships and Honorary Fellowships and recognised 46 members for 50 years of professional membership.”
• “Expanded the IBMS mentoring scheme, with 553 members registered as mentors and 187 as mentees, supporting career development across the profession.”
• “Participated in the Science Council EDI benchmarking exercise, demonstrating improvement across all 10 assessed areas since the previous review.”
• “Awarded £22,429 in bursaries to support member attendance at IBMS Congress 2025.”
• “Processed and approved 154 training approval applications.”
• “Increased the number of verifiers by 116 and 60 examiners compared with 2024.”
• “Delivered IBMS Congress 2025, attended by over 4,000 delegates, with the lecture programme covering more than 20 specialist areas.”
• “Hosted Biomedical Science Day celebrations at the Scottish Parliament and supported over 500 member-led public engagement events.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

9

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  —

  Not reported

• Cash

  +6.2%

  £2,743,891 → £2,915,270

• Net assets

  -4.9%

  £18,001,027 → £17,127,724

• Employees

  +11.8%

  34 → 38

• Wages

  +20.4%

  £1,548,413 → £1,865,037

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers